Class II

Drug Recall: Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 265

Mylan Institutional, Inc. · November 19, 2024

Reason for Recall

Subpotent and Superpotent Drug

Product Description

Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-039-20

Distribution

Nationwide in the USA.

States Affected

NATIONWIDE

Quantity Affected

988 cartons

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0132-2025

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.